Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease

NCT06917664 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT06917664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06917664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Phase 4
Overall status
Recruiting
Start date
June 5, 2025
Completion date
June 30, 2027
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angiotensin receptor/neprilysin inhibitor, coronary artery disease, ischemic mitral regurgitation